iShares Biotechnology ETF $IBB Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 12.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,531 shares of the financial services provider’s stock after buying an additional 5,625 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in iShares Biotechnology ETF were worth $8,937,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Basepoint Wealth LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at $29,000. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $25,000. Caitlin John LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter worth $34,000. Finally, Cornerstone Planning Group LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter worth $35,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $187.00 on Thursday. The company has a fifty day moving average of $178.75 and a two-hundred day moving average of $173.81. iShares Biotechnology ETF has a fifty-two week low of $130.25 and a fifty-two week high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.1%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.